Extracellular Myocardial Volume in Patients With Aortic Stenosis

[1]  B. Prendergast,et al.  2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). , 2022, Revista espanola de cardiologia.

[2]  M. Dweck,et al.  Sex differences in left ventricular remodelling, myocardial fibrosis and mortality after aortic valve replacement , 2019, Heart.

[3]  E. V. van Beek,et al.  Progression of Hypertrophy and Myocardial Fibrosis in Aortic Stenosis , 2018, Circulation. Cardiovascular imaging.

[4]  B. Prendergast.  Faculty of 1000 evaluation for 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2018 .

[5]  Richard B. Thompson,et al.  Myocardial native T1 and extracellular volume with healthy ageing and gender , 2018, European heart journal cardiovascular Imaging.

[6]  P. Kellman,et al.  Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis , 2018, Journal of the American College of Cardiology.

[7]  Y. Yoon,et al.  Noncontrast Myocardial T1 Mapping by Cardiac Magnetic Resonance Predicts Outcome in Patients With Aortic Stenosis. , 2017, JACC. Cardiovascular imaging.

[8]  M. Dweck,et al.  Myocardial Fibrosis and Cardiac Decompensation in Aortic Stenosis , 2017, JACC. Cardiovascular imaging.

[9]  M. Toyofuku,et al.  Acute Heart Failure in Patients With Severe Aortic Stenosis　- Insights From the CURRENT AS Registry. , 2017, Circulation journal : official journal of the Japanese Circulation Society.

[10]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.

[11]  S. K. White,et al.  Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients , 2017, European heart journal.

[12]  J. Chambers,et al.  Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[13]  Reza Nezafat,et al.  A medical device-grade T1 and ECV phantom for global T1 mapping quality assurance—the T1 Mapping and ECV Standardization in cardiovascular magnetic resonance (T1MES) program , 2016, Journal of Cardiovascular Magnetic Resonance.

[14]  J. Kautzner,et al.  Native T1 Relaxation Time and Extracellular Volume Fraction as Accurate Markers of Diffuse Myocardial Fibrosis in Heart Valve Disease　- Comparison With Targeted Left Ventricular Myocardial Biopsy. , 2016, Circulation Journal.

[15]  B. Gerber,et al.  Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T , 2015, Journal of Cardiovascular Magnetic Resonance.

[16]  D. Bluemke,et al.  Normal values for cardiovascular magnetic resonance in adults and children , 2015, Journal of Cardiovascular Magnetic Resonance.

[17]  Yong-Jin Kim,et al.  Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis. , 2015, Radiology.

[18]  David M Higgins,et al.  Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study , 2014, Journal of Cardiovascular Magnetic Resonance.

[19]  B. Gerber,et al.  Aortic Valve Area, Stroke Volume, Left Ventricular Hypertrophy, Remodeling, and Fibrosis in Aortic Stenosis Assessed by Cardiac Magnetic Resonance Imaging: Comparison Between High and Low Gradient and Normal and Low Flow Aortic Stenosis , 2013, Circulation. Cardiovascular imaging.

[20]  M. Robson,et al.  Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement , 2013, Journal of Cardiovascular Magnetic Resonance.

[21]  Tobias Schaeffter,et al.  Standardization of T1 measurements with MOLLI in differentiation between health and disease – the ConSept study , 2013, Journal of Cardiovascular Magnetic Resonance.

[22]  M. Robson,et al.  T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. , 2013, JACC. Cardiovascular imaging.

[23]  Andrew S Flett,et al.  Comprehensive Validation of Cardiovascular Magnetic Resonance Techniques for the Assessment of Myocardial Extracellular Volume , 2013, Circulation. Cardiovascular imaging.

[24]  Scott D Flamm,et al.  Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing , 2013, Journal of Cardiovascular Magnetic Resonance.

[25]  Andrew S Flett,et al.  Human non-contrast T1 values and correlation with histology in diffuse fibrosis , 2013, Heart.

[26]  Andrew S Flett,et al.  Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR , 2012, Journal of Cardiovascular Magnetic Resonance.

[27]  M. Dweck,et al.  Calcific aortic stenosis: a disease of the valve and the myocardium. , 2012, Journal of the American College of Cardiology.

[28]  P. Pibarot,et al.  Outcome of patients with aortic stenosis, small valve area, and low-flow, low-gradient despite preserved left ventricular ejection fraction. , 2012, Journal of the American College of Cardiology.

[29]  David A Bluemke,et al.  T1 mapping of the myocardium: Intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region , 2012, Journal of Cardiovascular Magnetic Resonance.

[30]  M. Hayward,et al.  Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans , 2010, Circulation.

[31]  Stefan Neubauer,et al.  Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations , 2009, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[32]  David M Higgins,et al.  Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heart , 2004, Magnetic resonance in medicine.

[33]  J. Schaper,et al.  Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human Heart: Structural Deterioration and Compensatory Mechanisms , 2003, Circulation.

[34]  O. Hess,et al.  Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. , 1989, Circulation.

[35]  V. Falk,et al.  Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology ( ESC ) and the European Association for CardioThoracic Surgery ( EACTS ) , 2017 .